Quarterly report pursuant to Section 13 or 15(d)

Debt (Tables)

v3.19.3
Debt (Tables)
9 Months Ended
Sep. 30, 2019
Debt Disclosure [Abstract]  
Schedule of Debt
At September 30, 2019 and December 31, 2018, we had notes payable and other debt (excluding the 2033 Senior Notes, the 2023 Convertible Notes, the 2025 Notes, the Credit Agreement and amounts outstanding under lines of credit described above) as follows:
(In thousands)
September 30,
2019
 
December 31,
2018
Current portion of notes payable
$
1,903

 
$
2,560

Other long-term liabilities
4,932

 
5,693

Total
$
6,835

 
$
8,253


The following table sets forth information related to the 2025 Notes which is included in our Condensed Consolidated Balance Sheet as of September 30, 2019:
(In thousands)
2025 Senior Notes
 
Discount
 
Debt Issuance Cost
 
Total
Balance at December 31, 2018
$

 
$

 
$

 
$

Issuance of 4.50% convertible notes
200,000

 
(52,600
)
 
(5,720
)
 
141,680

Amortization of debt discount and debt issuance costs

 
4,131

 
449

 
4,580

Balance at September 30, 2019
$
200,000

 
$
(48,469
)
 
$
(5,271
)
 
$
146,260


Summary of Lines of Credit
The following table summarizes the amounts outstanding under the BioReference, Chilean and Spanish lines of credit:
(Dollars in thousands)
 
 
 
 
 
 Balance Outstanding
Lender
 
Interest rate on
borrowings at September 30, 2019
 
Credit line
capacity
 
September 30,
2019
 
December 31,
2018
JPMorgan Chase
 
4.20%
 
$
100,000

 
$
50,644

 
$
105,198

Itau Bank
 
5.50%
 
1,810

 
1,027

 
232

Bank of Chile
 
6.60%
 
3,800

 
1,059

 
432

BICE Bank
 
5.50%
 
2,500

 
854

 
818

BBVA Bank
 
5.50%
 
3,250

 
11

 
858

Security Bank
 
5.50%
 
294

 
294

 

Estado Bank
 
5.50%
 
3,500

 
888

 
308

Santander Bank
 
5.50%
 
4,500

 
1,044

 
852

Scotiabank
 
5.00%
 
1,800

 
307

 
2

Banco De Sabadell
 
1.45%
 
327

 

 

Banco Bilbao Vizcaya
 
2.75%
 
327

 

 

Banco Santander
 
1.40%
 
327

 

 
10

Total
 
 
 
$
122,435

 
$
56,128

 
$
108,710